Trials / Recruiting
RecruitingNCT06629311
Platelet and Autotransfusion Device in Cardiac Surgery
Study of Platelet Count Changes During the Use of Autotransfusion Device in Cardiac Surgery
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Cardiac surgery is a bleeding-risk surgery and frequently requires blood transfusion. Intraoperative autotransfusion devices are used to aspirate, process and retransfuse patients' blood. These devices are effective in recovering red blood cells and limiting the need for transfusion of packed red blood cells. Some devices, such as I-SEP's SAME®, can also be used to recover platelets, but their effectiveness has not yet been evaluated in real-life situations. The aim of this study is therefore to investigate the evolution of platelet counts following the use of an intraoperative recovery device in adult patients undergoing standard cardiac surgery
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Autotransfusion device | Standard cardiac surgery using I-SEP and SAME™ autotransfusion device |
Timeline
- Start date
- 2025-02-04
- Primary completion
- 2026-09-08
- Completion
- 2026-09-08
- First posted
- 2024-10-08
- Last updated
- 2025-04-03
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06629311. Inclusion in this directory is not an endorsement.